Рапамун®

Active substance: sirolimus

раствор для приема внутрь, 1 мг/мл, 60 мл (original in Russian, GRLS)

RussiaActive

Marketing holder: Пфайзер Инк

Verified 2026-10-09 · GRLS (Russian state register)

Composition

Analogues by country

Products with the same active substance registered in other countries.

Country	Products
US 39	FYARRO INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · SIROLIMUS 5 mg/mL 80803-153 Aadi Bioscience, Inc. HYFTOR GEL · SIROLIMUS 2 mg/g 73683-101 Nobelpharma America, LLC SIROLIMUS SOLUTION · SIROLIMUS 1 mg/mL 31722-316 Camber Pharmaceuticals, Inc. Sirolimus SOLUTION · SIROLIMUS 1 mg/mL 69238-1594 Amneal Pharmaceuticals NY LLC Sirolimus SOLUTION · SIROLIMUS 1 mg/mL 16571-806 Rising Pharma Holdings, Inc. All products in this country (39)
EU 3	Hyftor sirolimus EMEA/H/C/005896 Plusultra pharma GmbH Opsiria sirolimus EMEA/H/C/003978 Santen Oy Rapamune sirolimus EMEA/H/C/000273 Pfizer Europe MA EEIG

Country

Products

US 39

FYARRO
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · SIROLIMUS 5 mg/mL
80803-153
Aadi Bioscience, Inc.
HYFTOR
GEL · SIROLIMUS 2 mg/g
73683-101
Nobelpharma America, LLC
SIROLIMUS
SOLUTION · SIROLIMUS 1 mg/mL
31722-316
Camber Pharmaceuticals, Inc.
Sirolimus
SOLUTION · SIROLIMUS 1 mg/mL
69238-1594
Amneal Pharmaceuticals NY LLC
Sirolimus
SOLUTION · SIROLIMUS 1 mg/mL
16571-806
Rising Pharma Holdings, Inc.

EU 3

Import and control

Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-d17e-7016-b64d-884b86e97f7a,01a120c3-daf1-7094-bce2-64d0d3745820,01a120c6-4cfd-717b-9e3c-8b590d4ab834,01a120c6-84c1-7cbb-993e-ebf349611da9;count=4 · valid from 2026-10-09 · verified 2026-10-09
United Statesprescription only
Source: openFDA NDC · record 01a1208c-2f11-7c1b-a72f-44533bc85422,01a1208c-ac9c-7d3e-8a87-99c18331a987,01a1208d-8db6-7aa4-a66b-0f225af0d48f,01a1208d-8eef-701b-9e60-7cc82b9002d8,01a1208d-cbef-7244-b070-c5a953411da8;count=39 · valid from 2026-10-09 · verified 2026-10-09